½ÃÀ庸°í¼­
»óǰÄÚµå
1597054

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå ¿¹Ãø(-2031³â)

Asia Pacific Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 136 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀåÀº 2023³â 7¾ï 5,266¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â¿¡´Â 15¾ï 1,433¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2023³âºÎÅÍ 2031³â±îÁöÀÇ CAGRÀº 9.1%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

´ë·® ¹é½Å Á¢Á¾¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿ø°ú Çõ½ÅÀûÀÎ °èȹÀÌ ¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¼¼°è Áúº´ ºÎ´ã(GBD)ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è °¢±¹ÀÇ Á¤ºÎ´Â °¡±Ý¿ë ¹é½Å Á¢Á¾¿¡ ´ëÇÑ Áö¿øÀ» Çϰí ÀÖ½À´Ï´Ù. ¸î °¡Áö ¿¹¹æ Á¢Á¾ ÇÁ·Î±×·¥ÀÌ Æ÷ÇԵ˴ϴÙ.

2022³â 12¿ù, Àεµ Á¤ºÎ´Â '°¡Ãà À§»ý¡¤Áúº´ °ü¸® ü°è'¿Í °°Àº °èȹÀÇ ½ÃÀÛÀ» ¹ßÇ¥Çß½À´Ï´Ù. ¶Ç, ÀÌ Á¦µµ´Â ¡¸Á¶»ç ¹× ±â¼ú Çõ½Å, È«º¸ ¹× °è¹ß, ¿¬¼ö °ü·Ã Ȱµ¿¡¹À» ´ë»óÀ¸·Î Çϰí ÀÖÀ¸¸ç, 100% Áß¾ÓÀÌ ÀÚ±ÝÀ» °ÅÃâÇϰí ÀÖ½À´Ï´Ù.

µû¶ó¼­ ÀÌ·¯ÇÑ Á¤ºÎÁö¿ø¿¡ ÀÇÇÑ Áý´Ü¿¹¹æÁ¢Á¾ÀÇ ÃßÁø°ú Çõ½ÅÀûÀÎ Á¦µµÀÇ ¼³°è´Â ÇâÈÄ ¸î ³â°£ÀÇ °¡±Ý½ÃÀåÀÇ ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀå °³¿ä

¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀåÀº Áß±¹, ÀϺ», Àεµ, È£ÁÖ, Çѱ¹ ¹× ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡·Î ±¸ºÐµË´Ï´Ù. ±â¾÷ÀÇ Á¸Àç, ´Ù¾çÇÑ Á¤ºÎ ±â°ü °ú µ¿¹° Çùȸ¿¡ ÀÇÇÑ ´ëó µîÀÇ ¿äÀο¡ ÀÇÇØ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀåÀÇ ¼öÀͰú 2031³â±îÁöÀÇ ¿¹Ãø(´ÜÀ§: 100¸¸ ´Þ·¯)

¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀå ¼¼ºÐÈ­

¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀåÀº À¯Çüº°, ±â¼úº°, Åõ¿©Çüº°, Áúȯº°, Åõ¿©°æ·Îº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°·Î ºÐ·ùµË´Ï´Ù.

À¯Çüº°·Î ¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀåÀº À°°è¿Í ·¹À̾î·Î 2ºÐÈ­µË´Ï´Ù.

±â¼ú Ãø¸é¿¡¼­ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý·ù ¹é½Å ½ÃÀåÀº ¾àµ¶»ý ¹é½Å, ºÒȰȭ ¹é½Å, ÀçÁ¶ÇÕ ¹é½ÅÀ¸·Î ºÐ·ùµË´Ï´Ù.

Á¦Çüº°·Î, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý·ù ¹é½Å ½ÃÀåÀº ¾×ü ¹é½Å, µ¿°á°ÇÁ¶ ¹é½Å, ºÐ¸»/ºÐü ¹é½ÅÀ¸·Î ±¸ºÐµË´Ï´Ù. 2023³â¿¡´Â ¾×ü ¹é½ÅÀÌ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Áúº´º°·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý·ù ¹é½Å ½ÃÀåÀº Á¶·ù ÀÎÇ÷翣ÀÚ, Àü¿°¼º ±â°üÁö¿°, ¸»·ºº´, Á¶·ù »ì¸ð³Ú¶óÁõ, Àü¿°¼º Ȱ¾×Æ÷¿°(IBD), ´ºÄ³½½º´ µîÀ¸·Î ºÐ·ùµË´Ï´Ù. 2023³â¿¡ Á¶·ùµ¶°¨ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Åõ¿© °æ·Îº°·Î ¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀåÀº ½Ä¼ö(D/W), ±ÙÀ°³» Åõ¿©(I/M), ÇÇÇÏ Åõ¿©(I/S) µîÀ¸·Î ±¸ºÐµË´Ï´Ù. ½Ä¼ö(D/W) ºÎ¹®Àº 2023³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀåÀº ¾ç°èÀå, ºÎÈ­Àå, µ¿¹°º´¿ø, °¡±Ý¿ë ¹é½ÅÁ¢Á¾¼¾ÅÍ, Ŭ¸®´ÐÀ¸·Î ±¸ºÐµË´Ï´Ù. ¾ç°èÀå ºÎÈ­Àå ºÎ¹®ÀÌ 2023³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î ¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀåÀº Áß±¹, Àεµ, ÀϺ», È£ÁÖ, Çѱ¹ ¹× ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡·Î ±¸ºÐµË´Ï´Ù. 2023³â¿¡´Â Áß±¹ÀÌ ¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý·ù ¹é½Å ½ÃÀå Á¡À¯À²À» µ¶Á¡Çß½À´Ï´Ù.

Boehringer Ingelheim International GmbH, Zoetis Inc, Phybro Animal Health Corp, Hester Biosciences Ltd, Venky's(India) Ltd, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, Nisseiken Co Ltd, Vaccinova AB.´Â ¾Æ½Ã¾ÆÅÂÆò¾ç¿ë ¹é½Å ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °¡±ÝÁúȯÀÇ À¯º´·ü »ó½Â
    • °¡±Ý»ê¾÷ÀÇ ¼ºÀå
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿¹¹æÁ¢Á¾ ½ÇÆÐ¿Í ºÎÀûÀýÇÑ Ãë±Þ
  • ½ÃÀå ±âȸ
    • ´ë·® ¹é½ÅÁ¢Á¾¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿ø°ú Çõ½ÅÀûÀΠü°è
  • ÇâÈÄÀÇ µ¿Çâ
    • º¤ÅÍ ¹é½Å ¹× È¥ÇÕ ¹é½ÅÀÇ Áøº¸
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦5Àå ¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý¿ë ¹é½Å ½ÃÀå ºÐ¼®

  • °¡±Ý¿ë ¹é½Å ½ÃÀå ¼öÀÍ(2021-2031³â)

Á¦6Àå ¾Æ½Ã¾ÆÅÂÆò¾ç °¡±Ý¿ë ¹é½Å ½ÃÀå ºÐ¼® : À¯Çüº°

  • À°°è(À°¿ë ´ß)
  • ·¹À̾î(°è¶õ¿ë ´ß)

Á¦7Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå ºÐ¼® : ±â¼úº°

  • »ý¹é½Å
  • ºÒȰ¼ºÈ­ ¹é½Å
  • ÀçÁ¶ÇÕ ¹é½Å

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå ºÐ¼® : Á¦Çüº°

  • ¾×ü ¹é½Å
  • ÇÁ¸®Áî µå¶óÀÌ ¹é½Å
  • ºÐ¸» ¹é½Å

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå ºÐ¼® : Áúȯº°

  • Á¶·ù ÀÎÇ÷翣ÀÚ
  • Á¶·ù »ì¸ð³Ú¶óÁõ
  • ¸»·ºº´
  • °¨¿°¼º ±â°üÁö¿°(IB)
  • °¨¿°¼º Ȱ¾×Æ÷¿°(IBD)
  • ´ºÄ³½½º´
  • ±âŸ

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå ºÐ¼® : Åõ¿©°æ·Îº°

  • ½Ä¼ö(D/W)
  • ±ÙÀ°³» Åõ¿©(I/M)
  • ÇÇÇÏ Åõ¿©(S/C)
  • ±âŸ

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¾ç°èÀå
  • µ¿¹°º´¿ø
  • °¡±Ý¿ë ¹é½Å Á¢Á¾ ¼¾ÅÍ, Áø·á¼Ò

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå : ±¹°¡º° ºÐ¼®

  • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå °³¿ä
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡

Á¦13Àå ¾÷°è Á¤¼¼

  • °¡±Ý¿ë ¹é½Å ½ÃÀå¿¡¼­ÀÇ ¼ºÀå Àü·«
  • À¯±âÀû Àü°³
  • ¹«±âÀû Àü°³

Á¦14Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • Phibro Animal Health Corp
  • Hester Biosciences Ltd
  • Venky's(India) Ltd
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc
  • Merck KGaA
  • Ceva
  • Nisseiken Co Ltd
  • Vaccinova AB

Á¦15Àå ºÎ·Ï

JHS 24.12.04

The Asia Pacific poultry vaccines market was valued at US$ 752.66 million in 2023 and is expected to reach US$ 1,514.33 million by 2031; it is estimated to record a CAGR of 9.1% from 2023 to 2031.

Government Support for Mass Vaccination Drives and Innovative Schemes Boost Asia Pacific Poultry Vaccines Market

Government worldwide is supportive against poultry vaccination with rising Global Burden of Disease (GBD). The support involves launching of mass vaccination schemes and several vaccination programs at vaccination centers or through door-step immunization services.

In December 2022, the Indian Government announced launching of schemes such as the "Livestock Health & Disease Control Scheme" improve the animal health sector by implementing prophylactic vaccination programs against several diseases. This scheme is Central or State-driven and funded with a sharing pattern of 60:40. Also, the scheme covers "research & innovation, publicity & awareness, training & allied activities" that are 100% Center-funded.

Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years.

Asia Pacific Poultry Vaccines Market Overview

The Asia Pacific poultry vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in Asia Pacific is expected to grow considerably owing to factors such as the increasing incidences of livestock diseases, the rising incidences of zoonotic diseases, the presence of leading players, and initiatives taken by various government agencies and animal associations. Further, developing healthcare infrastructure and increasing per capita animal healthcare expenditure are projected to drive the Asia Pacific poultry vaccines market during the forecast period.

Asia Pacific Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Poultry Vaccines Market Segmentation

The Asia Pacific poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the Asia Pacific poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the Asia Pacific poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the Asia Pacific poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the Asia Pacific poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the Asia Pacific poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the Asia Pacific poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the Asia Pacific poultry vaccines market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Hester Biosciences Ltd, Venky's (India) Ltd, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, Nisseiken Co Ltd, and Vaccinova AB. are some of the leading companies operating in the Asia Pacific poultry vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

4. Asia Pacific Poultry Vaccines Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Poultry Diseases
    • 4.1.2 Growing Poultry Industry
  • 4.2 Market Restraints
    • 4.2.1 Vaccination Failure and Improper Handling
  • 4.3 Market Opportunities
    • 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
  • 4.4 Future Trends
    • 4.4.1 Advancements in Vectored and Combination Vaccines
  • 4.5 Impact of Drivers and Restraints:

5. Asia Pacific Poultry Vaccines Market Analysis

  • 5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031

6. Asia Pacific Poultry Vaccines Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Broiler
    • 6.2.1 Overview
    • 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Layer
    • 6.3.1 Overview
    • 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Poultry Vaccines Market Analysis - by Technology

  • 7.1 Overview
  • 7.2 Live Attenuated Vaccines
    • 7.2.1 Overview
    • 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Inactivated Vaccines
    • 7.3.1 Overview
    • 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Recombinant Vaccines
    • 7.4.1 Overview
    • 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Poultry Vaccines Market Analysis - by Dosage Form

  • 8.1 Overview
  • 8.2 Liquid Vaccines
    • 8.2.1 Overview
    • 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Freeze-Dried Vaccines
    • 8.3.1 Overview
    • 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Dust/Powdered Vaccines
    • 8.4.1 Overview
    • 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Poultry Vaccines Market Analysis - by Disease

  • 9.1 Overview
  • 9.2 Avian Influenza
    • 9.2.1 Overview
    • 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Avian Salmonellosis
    • 9.3.1 Overview
    • 9.3.2 Avian Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Marek's Disease
    • 9.4.1 Overview
    • 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Infectious Bronchitis (IB)
    • 9.5.1 Overview
    • 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Infectious Bursal Disease (IBD)
    • 9.6.1 Overview
    • 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Newcastle Disease
    • 9.7.1 Overview
    • 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Poultry Vaccines Market Analysis - by Route of Administration

  • 10.1 Overview
  • 10.2 Drinking Water (D/W)
    • 10.2.1 Overview
    • 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Intramuscular (I/M)
    • 10.3.1 Overview
    • 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Subcutaneous (S/C)
    • 10.4.1 Overview
    • 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Poultry Vaccines Market Analysis - by End User

  • 11.1 Overview
  • 11.2 Poultry Farms
    • 11.2.1 Overview
    • 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Veterinary Hospitals
    • 11.3.1 Overview
    • 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Poultry Vaccination Centers & Clinics
    • 11.4.1 Overview
    • 11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Poultry Vaccines Market - Country Analysis

  • 12.1 Asia Pacific Market Overview
    • 12.1.1 Poultry Vaccines Market Breakdown by Countries
      • 12.1.1.1 China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Overview
        • 12.1.1.1.2 China: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.1.3 China: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.1.4 China: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.1.5 China: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.1.6 China: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.1.7 China: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.2 India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 Overview
        • 12.1.1.2.2 India: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.2.3 India: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.2.4 India: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.2.5 India: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.2.6 India: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.2.7 India: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.3 Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Overview
        • 12.1.1.3.2 Japan: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.3.3 Japan: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.3.4 Japan: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.3.5 Japan: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.3.6 Japan: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.3.7 Japan: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.4 Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 Overview
        • 12.1.1.4.2 Australia: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.4.3 Australia: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.4.4 Australia: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.4.5 Australia: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.4.6 Australia: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.4.7 Australia: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.5 South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Overview
        • 12.1.1.5.2 South Korea: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.5.3 South Korea: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.5.4 South Korea: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.5.5 South Korea: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.5.6 South Korea: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.5.7 South Korea: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.6 Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Overview
        • 12.1.1.6.2 Rest of APAC: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.6.3 Rest of APAC: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.6.4 Rest of APAC: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.6.5 Rest of APAC: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.6.6 Rest of APAC: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.6.7 Rest of APAC: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Poultry Vaccines Market
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.1 Inorganic Developments
    • 13.1.1 Overview

14. Company Profiles

  • 14.1 Boehringer Ingelheim International GmbH
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Zoetis Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Phibro Animal Health Corp
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Hester Biosciences Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Venky's (India) Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Dechra Pharmaceuticals PLC
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Elanco Animal Health Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Merck KGaA
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Ceva
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Nisseiken Co Ltd
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Vaccinova AB
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦